))
Knowing Silicosis: The Inhalation of Silica Dust
Manage episode 375300170 series 2993661
Sisällön tarjoaa Dung Trinh. Dung Trinh tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
About the Guest:
Kate Chiang is a Clinical Research Associate and a Medical Student at University College Dublin. She is a TongueOut Youth Ambassador and also a Research and Development Scientist/Co-founder at KARE Biosciences. At KARE Biosciences, she continues to research the therapeutic benefits of Ramatroban, write manuscripts, apply for grants, create graphics, analyze data, run social media, and help with e-mail communications. She has been working to repurpose Ramatroban as an antithrombotic agent and immunomodulator for the treatment of COVID-19, long COVID, sickle cell disease, cancer, kidney disease and more.
In this episode, you’ll learn about:
- The drug called Ramatroban
- Introduction to Silicosis
- Fibrosis Demographic
- Lipid Mediator Storm
- Availability of Ramatroban
- The Potential of Ramatroban
- The Future of Medicine
Connect with Kate Chiang:
About the Host:
Dung Trinh, MD is the Chief Medical Officer of Healthy Brain Clinic, a medical missionary with TongueOut Medical Missions, and holds leadership positions with multiple healthcare organizations in Orange County. He is a keynote speaker, best-selling author, and Host of “Health Talks with Dr. Trinh” which can be heard weekly on OC Talk Radio.
Connect with Dr. Trinh
- HealthTalks OC Website
- Tongue Out
- Facebook Page
- Facebook (Personal Account)
- YouTube
- Healthy Brain Clinic
A Team Dklutr Production
71 jaksoa
Jaa
